Abstract
Proteins have been labeled with halogen isotopes for many years. These tracers have been exploited as probes of protein metabolism and pharmacokinetics in vivo and have provided invaluable tools for use in radioimmunoassay. Because of this extensive experience with radioiodinated proteins and the direct applicability of in vitro data obtained with I-125, labeling with halogen isotopes has been an attractive approach to the development of monoclonal antibodies as agents for radioimmunodiagnostic and therapeutic applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
V. I. Vedeneyev, L. V. Gurvich, V. N. Kondrat’yev, V. A. Medvedev and Y. L. Frankevich, “Bond Energies, Ionization Potentials and Electron Affinities”, St. Martin’s Press, New York (1966).
K. Berei and L. Vasaros, Organic chemistry of astatine, Hungarian Academy of Sciences Report KFKI-1981-10 p, 41 (1981).
A. S. McFarlane, Efficient trace-labelling of proteins with iodine, Nature 182:53 (1958).
U. Rosa, G. A. Scassellati, F. Pennisi, N. Riccioni, P. Giagnoni, and R. Giordani, Labelling of human fibrinogen with I-131 by electrolytic iodination, Biochem. Biophys. Acta 86:519 (1964).
W. M. Hunter and F. C. Greenwood, Preparation of iodine-131 labelled human growth hormone of high specific activity, Nature 194:495 (1962).
M. A. K. Markwell, A new solid state reagent to iodinate proteins, Anal. Biochem. 125:427 (1983).
W. R. Butt, The iodination of Follicle-stimulating and other hormones for radioimmunoassay, Enocrinology 55:453 (1972).
F. Tejedor and J. P. G. Ballesta, Iodination of biological samples without loss of functional activity, Anal. Biochem. 127:143 (1982).
J. J. Marchalonis, An enzymatic method for the trace iodination of immunoglobulins and other proteins, Biochem. J. 113:299 (1969).
L. Knight, K. A. Krohn, M. J. Welch, B. Spomer and L. P. Hager, Br-77: A new protein label, in: “Radiopharmaceuticals”, G. Subramanian, B. A. Rhodes, J. F. Cooper, and V. J. Sodd, eds., Society of Nuclear Medicine, New York (1975).
K. D. McElvany and M. J. Welch, Characterization of bromine-77-labeled proteins prepared using bromoperoxidase, J. Nucl. Med. 21:953 (1980).
G. S. David, Solid state lactoperoxidase:. A highly stable enzyme for simple, gentle iodination of proteins, Biochem. Biophys. Res. Comm. 48:464 (1972).
G. S. David and R. A. Reisfeld, Protein iodination with solid state lactoperoxidase, Biochem. 13:1014 (1974).
P. J. Fraker and J. C. Speck, Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3 α-6α-diphenylglycouril, Biochem. Biophys. Res. Comm. 80:849 (1978).
M. R. Zalutsky, D. F. Hayes, and D. W. Kufe, Radioiodination of DF3 antibody: Optimization using in vitro binding assays, J. Label. Cmpd. Radiopharm. (in press).
P. Reay, Use of N-bromosuccinimide for the iodination of proteins for radioimmunoassay, Ann. Clin. Chem. 19:129 (1982).
A. E. Bolton and W. M. Hunter, The labelling of proteins to high specific activities by conjugation to a I-125-containing acylating agent, Biochem. J. 133:529 (1973).
A. E. Bolton, V. Lee-Own, R. Kramer McLean, and G. S. Challand, Three different radioiodinat ion methods for human spleen ferritin compared, Clin. Chem. 25:1826 (1979).
V. S. Chang, H. W. Cho, and H. Y. Meltzer, Labeling of creatinine phosphokinase without loss of enzyme activity, Biochem. Biophys. Res. Comm. 65:413 (1975).
L. C. Knight, S. S. L. Harwig and M. J. Welch, In vitro stability and in vivo clearance of fibrinogen or serum albumin labeled with Br-77, I-131, I-125 by direct or indirect synthetic methods, J. Nucl. Med. 18:282 (1977).
F. T. Wood M. M. Wu, and J. C. Gerhart, The radioactive labeling of proteins with an iodinated amidation reagent, Anal. Biochem. 69:339 (1975).
C. E. Hayes and I. J. Goldstein, Radioiodinat ion of sulfhydryl-sensitive proteins, Anal. Biochem. 67:580 (1975).
M. R. Zalutsky, A. M. Friedman, F. Buckingham, W. Wung, F. P. Stuart, and S. J. Simonian, Synthesis of a non-labile astatine-protein conjugate, J. Label Cmpd Radiopharm. 13:181 (1977).
G. W. Barendsen, T. L. J. Beusker, A. J. vergroesen, and L. Budke, Effects of different ionizing radiations on human cells in tissue culture, Radiation Res. 13:841 (1960).
E. L. Lloyd, M. A. Gammell, C. B. Henning, D. S. Ganmell, and B. J. Zabransky, Cell survival following multiple-track alpha particle irradiation Int. J. Radiat. Biol. 35:23 (1979).
C. Aaij, W. R. J. M. Tschrotts, L. Lendner, and T. E.W. Feltkamp, The preparation of astatine labeled proteins, Int. J. Appl. Radiat. Isot. 26:25 (1975).
A. T. M. Vaughan and J. H. Fremlin, The preparation of astatine labeled proteins using an electrophilic reaction, Int. J. Nucl., Med. Biol. 5:229 (1978).
G. W. M. Visser, E. L. Diemer, and F. M. Kaspersen, The preparation and stability of astatotyrosine and astatoiodotyrosine, Int. J. Appl. Radiat. Isot. 30:749 (1979).
G. W. M. Visser, E. L. Diemer, and F. M. Kaspersen, The nature of the astatine-protein bond, Int. J. Appl. Radiat. Isot. 32:905 (1981).
A. M. Friedman, M. R. Zalutsky, W. Wung, F. Buckingham, P. V. Harper, G. H. Sherr, B. Wainer, R. L. Hunter, E. H. Appelman, R. M. Rothberg, F. W. Fitch, F. P. Stuart, and S. J. Simonian, Preparation of a biologically stable and immunogenically competent astatinated protein, Int. J. Nucl. Med. Biol. 4:219 (1977).
A. T. M. Vaughan, The labeling of proteins with At-211 using an acylation reaction, Int. J. Appl. Radiat. Isot. 30:576 (1979).
A. Harrision and L. Royle, Preparation of a At-211-IgG conjugate which is stable in vivo, Int. J. Appl. Radiat. Isot. 35:1005 (1984).
A. T. M. Vaughan, W. J. Bateman, and J. Cowan, The preparation and cytotoxic properties of 211At labelled concanavalin A bound to cell membranes, J. Radioanal. Chem. 64:33 (1981).
A. T. M. Vaughan, W. J. Bateman, And D. R. Fisher, The in vivo fate of a 211At labelled monoclonal antibody with known specificity in a murine system, Int. J. Radiat. Oncol. Biol. Phys. 8:1943 (1982).
A. T. M. Vaughan, W. J. Bateman, G. Brown, and J. Cowan, The specific inhibition of cellular clonogenic proliferation using At-211 labelled lectins and antibodies-I, Int. J. Nucl. Med. Biol. 9:167 (1982).
W. J. Bateman, A. T. M. Vaughan, and G. Brown, Tumour localization of 211At labelled monoclonal antibody to a subcutaneous human heterograft in the nude mouse II, Int. J. Nucl. Med. Biol. 4:241 (1983).
E. A. Kabat, T. T. Wu, and H. Bilofsky, Immunoglobulin sequences, NIH Publication No. 80-2008, p1, NIH, Bethesda, MD. (1979).
B. -K. Seon, O. A. Robolt and D. Pressman, Reactivity of tyrosine residues in the constant portion of type K Bence Jones protein, Biochem. Biophys. Acta. 200:81 (1970).
S. K. Dube, O. A. Roholt and D. Pressman, Relative reactivity to iodination of tyrosine residues in α-chymotrypsin, J. Biol. Chem. 241:4665 (1965).
A. L. Grossberg, G. Radzimski, and D. Pressman, Effect of iodination on the active site of several antihapten antibodies, Biochem. 1:391 (1962).
Y. Shechter, Y. Burstein, and A. Patchornik, Selective oxidation of methionine residues in proteins, Biochem. 14:4497 (1975).
N. M. Alexander, Oxidative cleavage of tryptophanyl peptide bonds during chemical-and peroxidase-cata1yzed iodinations, J. Biol. Chem. 249:1946 (1974).
L. A. Sherman, S. Harwig, and O. A. Hayne, Macromolecular complexes formed as the result of chloramine-T radio-iodination of proteins, Int. J. Appl. Radiat. Isot. 25:81 (1974).
D. F. Hayes, M. R. Zalutsky, W. Kaplan, M. Noska, A. Thor, D. Colcher, and D. W. Kufe, Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer, Cancer Res. 46:3157 (1986).
D. C. Sullivan, J. S. Silva, C. E. Cox, D. E. Haagensen, Jr., C. C. Harris, W. H. Briner, and S. A. Wells, Jr., Localization of I-131 labeled goat and primate anti-carcinoembryonic antigen (CEA) antibodies in patients with cancer, Invest. Radiol. 17:350 (1982).
P. Dumas, Deshalogenation de divers derives iodes phenoliques chez le rat normal et. thyroidectomise, Biochem. Pharmacol. 22:1599 (1973).
W. Tong, A. Taurog, and I. L. Chaikoff, The metabolism of I-131-labeled diiodotyrosine, J. Biol. Chem. 207:59 (1954).
J. B. Stanbury and M. L. Morris, Deiodination of diodotyrosine by cell-free systems, J. Biol. Chem. 233:106 (1958).
I. J. Chopra, A study of extrathyroidal conversion of thyroxine (T4) to 3, 3′, 5,-triiodothyronine (T3) in vitro, Endocrinology 101:453 (1977).
M. M. Kaplan and R. D. Utiger, Iodothyronine metabolism in rat liver homogenates J. Clin. Invest. 61:459 (1978).
R. Ientile, S. Macaione, P. Russo, G. Pugliese, and R. DiGiorgio, Phenolic and tyrosyl ring deiodination in thyroxine from rat retina during postnatal development, Eur. J. Biochem. 142:15 (1984).
R. C. Smallridge and N. E. Whorton, 3′-monoiodothyronine degradation in rat liver homogenate: Enzymatic characteristics and documentation of deiodination by high-pressure liquid chromatography Metabolism 33:1034 (1984).
R. C. Smallridge, K. D. Burman, K. E. Ward, L. Wartofsky, R. C. Dimond, F. D. Wright, and K. R. Latham, 3′,5′ -diiodothyronine to 3′-mono-iodothyronine conversion in the fed and fasted rat: Enzyme characteristics and evidence for two distinct S′-deiodinases, Endocrinology 108:2336 (1981).
J. L. Leonard and I. N. Rosenbert, Subcellular distribution of thyroxine S′-deiodinase in the rat kidney: A plasma membrane location, Endocrinology 103:274 (1977).
M. R. Zalutsky, D. Colcher, W. Kaplan, And D. F. Kufe, Radioiodinated B6.2 monoclonal antibody: Further characterization of a potential radiopharmaceutical for the identification of breast tumors, Int. J. Nucl. Med. Biol. 12:227 (1985).
D. S. Wilbur, D. S. Jones, A. R. Fritzberg, and A. C. Morgan, Radioiodination of monoclonal antibodies, Labeling with para-iodophenyl (PIP) derivatives for in vivo stability of the radioiodine label, J. Nucl. Med. 27:959 (1986) abstract.
J. L. Goldstein and M. S. Brown, Binding and degradation of low density lipoproteins by cultured human fibroblasts, J. Biol. Chem. 249:5153 (1974).
S. Terris and D. F. Steiner, Binding and degradation of I-125-insulin by rat hepatocytes, J. Biol. Chem. 250:8389 (1975).
G. Carpenter and S. Cohen, 125I-labeled human epidermal growth factor: Binding, internalization and degradation in human fibroblasts, J. Cell Biol. 71:159 (1976).
A. S. H. DeJong, J. M. W. Bouma, and M. Gruber, O-(4-diazo-3,5-di[I-125]iodobenzoy1-sucrose, a novel radioactive label for determining organ sites of catabolism of plasma proteins, Bio. Chem. J. 198:45 (1981).
R. C. Pittman, T. E. Carew, C. K. Glass, S. R. Green, C. A. Taylor, Jr., and A. D. Attie, A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo, Biochem. J. 212:791 (1983).
M. R. Zalutsky and A. Narula, A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine, Appl. Radiat. Isot. 38:1051 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this paper
Cite this paper
Zalutsky, M.R. (1988). Radiohalogenation of Antibodies: Chemical Aspects. In: Srivastava, S.C. (eds) Radiolabeled Monoclonal Antibodies for Imaging and Therapy. NATO ASI Series, vol 152. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5538-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5538-0_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5540-3
Online ISBN: 978-1-4684-5538-0
eBook Packages: Springer Book Archive